Articles From: Aptose Biosciences to Present at Biotech Showcase™ 2015 to Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis


2015/1/12
SAN DIEGO, CA and TORONTO , Jan.
Sign-up for Aptose Biosciences to Present at Biotech Showcase™ 2015 investment picks
2015/1/12
By Angela Chen Bristol-Myers Squibb Co.
Sign-up for Bristol-Myers Squibb jumps on Opdivo cancer drug test investment picks
2015/1/12
Build-A-Bear Workshop, Inc. (NYSE:BBW) today issued preliminary sales and guidance for adjusted pre-tax income for the fourth quarter and fiscal year 2014 ended January 3, 2015 in conjunction with its presentation at the 17 th Annual ICR XChange Conference.
Sign-up for Build-A-Bear Workshop, Inc. Issues Preliminary Sales and Pre-Tax Earnings Expectations Ahead of Presentation at ICR XChange investment picks
2015/1/12
http://www.ccnmatthews.com/logos2/cn_blueS.gif CALGARY, ALBERTA --
Sign-up for Canadian Natural Resources Limited Announces the Use of Capital Flexibility in Its 2015 Budget investment picks
2015/1/12
AMSTERDAM , Jan.
Sign-up for Core Lab Announces Q1 2015 Quarterly Dividend; Increases Quarterly Dividend By 10% To $0.55 Per Share investment picks
2015/1/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168486&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for Equus Dispositions Yield $3.6 Million in Cash and a $0.9 Million Note investment picks
2015/1/12
Exact Sciences Corp.
Sign-up for Exact Sciences Offers Update on Cologuard’s® Early Launch Trajectory investment picks
2015/1/12
Glimcher Realty Trust (“Glimcher”) (NYSE: GRT) announced that its common shareholders approved the acquisition of Glimcher by Washington Prime Group Inc. (“WPG”) (NYSE: WPG) at its special meeting of shareholders held earlier today.
Sign-up for Glimcher Shareholders Approve Acquisition by Washington Prime investment picks
2015/1/12
PASADENA, Calif., Jan.
Sign-up for Green Dot to Announce Fourth Quarter 2014 Results on January 29th investment picks
2015/1/12
Second Sight Medical Products, Inc. (Nasdaq: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that Health Canada has approved the Argus® II Retinal Prosthesis System to treat individuals with severe to profound outer retinal degeneration.
Sign-up for Health Canada Approves Second Sight’s Argus II Retinal Prosthesis System for Treatment of Outer Retinal Degeneration investment picks
2015/1/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168437&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle and Proteus Integrate Proteus Digital Health Feedback System With Oracle Health Sciences InForm to Help Increase Clinical Trial Accuracy investment picks
2015/1/12
Retrophin, Inc. (NASDAQ:RTRX) and Asklepion Pharmaceuticals, LLC, a privately held rare disease pharmaceutical development company, today announced the signing of a definitive agreement under which Retrophin has acquired the exclusive right to purchase from Asklepion, all worldwide rights, titles, and ownership of cholic acid for the treatment of bile acid synthesis defects, if approved by the U.S. Food and Drug Administration (FDA). Under the terms of the agreement, Retrophin will pay Asklepion an upfront payment of $5 million and up to $73 million in milestones based on approval and net product sales, plus tiered royalties on future net sales of cholic acid.
Sign-up for Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals investment picks
2015/1/12
Broadband and space innovators team to deliver most powerful satellite into orbit ViaSat-2 designed to enable significantly more data per user CARLSBAD, Calif.
Sign-up for ViaSat Selects SpaceX to Launch ViaSat-2 Satellite investment picks
2015/1/12
SAN DIEGO, Jan.
Sign-up for Vital Therapies Provides Clinical and Regulatory Update investment picks
2015/1/12
Wayfair Inc. (NYSE:W), one of the world’s largest online destinations for home furnishings and décor, today reported a 51 percent increase in overall gross sales, defined as dollars of order intake, and a 76 percent increase in Direct Retail gross sales for the five-day peak shopping period of Thanksgiving Day through Cyber Monday.
Sign-up for Wayfair Reports Record Growth for Peak Five-Day Holiday Shopping Weekend investment picks
2015/1/12
EL PASO, Texas, Jan.
Sign-up for Western Refining Logistics to Participate in the 2015 UBS MLP Conference investment picks
2015/1/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168565&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Worldwide Diversified Holdings, Inc. CEO Interviewed on Radio Program investment picks
2015/1/9
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Wall Street is bracing for a 20% decline in energy companies' earnings in the fourth quarter -- and that's the good news.
Sign-up for Energy stocks brace for many quarters of earnings pressure investment picks
2015/1/9
CHAMPAIGN, Ill., Jan.
Sign-up for First Busey Corporation Announces the Acquisition of Herget Financial Corp. and Herget Bank, National Association investment picks
2015/1/9
http://www.ccnmatthews.com/logos2/223mmt.jpg CALGARY, ALBERTA --
Sign-up for Mart Resources, Inc.: UMU-13 Initial Flow Test Results, Drilling Update, and Dividend Update investment picks
2015/1/9
Nate’s Food Co.
Sign-up for Nate’s Food Co. Announces Shareholder Event for January 30, 2015 investment picks
2015/1/9
Tucson Community Sustains Its "Appetite" for Natural Food Choices TUCSON, Ariz.
Sign-up for Natural Grocers Set to Open Store in Tucson on January 20 investment picks
2015/1/9
The Procter & Gamble Company (NYSE:PG) recognized seven of its top performing External Business Partners with its prestigious Partner of the Year award yesterday.
Sign-up for P&G Recognizes Top Performing Global Partners investment picks
2015/1/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168273&ProfileId=051205&sourceType=1 POMPANO BEACH, FL --
Sign-up for Stonegate Bank Completes Acquisition of Community Bank of Broward investment picks
2015/1/9
The House of Representatives passed a bill Friday to approve building the Keystone XL pipeline.
Sign-up for UPDATE: House passes bill to approve building Keystone XL pipeline investment picks
2015/1/8
BOULDER, Colo.
Sign-up for Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference investment picks
2015/1/8
http://www.ccnmatthews.com/logos/20110930-harvest.JPG http://media3.marketwire.com/docs/AUSlogoLRG.png http://media3.marketwire.com/docs/BLIFlogo200.jpg http://media3.marketwire.com/logos/20140812-BRANDL.jpg http://media3.marketwire.com/logos/20120329-elifa.jpg http://media3.marketwire.com/logos/20140903-ener0903.jpg OAKVILLE, ONTARIO --
Sign-up for Australian REIT Income Fund (HRR.UN), Brand Leaders Income Fund (HBL.UN), Brand Leaders Plus Income Fund (HBF.UN), Energy Leaders Income Fund (HEN.UN) and Energy Leaders Plus Income Fund (HPF.UN) investment picks
2015/1/8
Biogen Idec (NASDAQ: BIIB) today announced top-line results from the Phase 2 acute optic neuritis (AON) RENEW trial in which treatment with anti-LINGO-1 showed evidence of biological repair of the visual system.
Sign-up for Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Aptose Biosciences to Present at Biotech Showcase™ 2015 to Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent